1. Home
  2. XELB vs IKT Comparison

XELB vs IKT Comparison

Compare XELB & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XELB
  • IKT
  • Stock Information
  • Founded
  • XELB 2011
  • IKT 2008
  • Country
  • XELB United States
  • IKT United States
  • Employees
  • XELB N/A
  • IKT N/A
  • Industry
  • XELB Multi-Sector Companies
  • IKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • XELB Miscellaneous
  • IKT Health Care
  • Exchange
  • XELB Nasdaq
  • IKT Nasdaq
  • Market Cap
  • XELB 16.0M
  • IKT 13.4M
  • IPO Year
  • XELB N/A
  • IKT 2020
  • Fundamental
  • Price
  • XELB $0.71
  • IKT $1.24
  • Analyst Decision
  • XELB
  • IKT Strong Buy
  • Analyst Count
  • XELB 0
  • IKT 1
  • Target Price
  • XELB N/A
  • IKT $15.00
  • AVG Volume (30 Days)
  • XELB 24.7K
  • IKT 24.6K
  • Earning Date
  • XELB 08-14-2024
  • IKT 08-14-2024
  • Dividend Yield
  • XELB N/A
  • IKT N/A
  • EPS Growth
  • XELB N/A
  • IKT N/A
  • EPS
  • XELB N/A
  • IKT N/A
  • Revenue
  • XELB $10,062,000.00
  • IKT $79,570.00
  • Revenue This Year
  • XELB N/A
  • IKT N/A
  • Revenue Next Year
  • XELB $82.99
  • IKT N/A
  • P/E Ratio
  • XELB N/A
  • IKT N/A
  • Revenue Growth
  • XELB N/A
  • IKT N/A
  • 52 Week Low
  • XELB $0.58
  • IKT $0.79
  • 52 Week High
  • XELB $1.70
  • IKT $3.82
  • Technical
  • Relative Strength Index (RSI)
  • XELB 51.41
  • IKT 44.01
  • Support Level
  • XELB $0.66
  • IKT $1.17
  • Resistance Level
  • XELB $0.71
  • IKT $1.51
  • Average True Range (ATR)
  • XELB 0.01
  • IKT 0.12
  • MACD
  • XELB -0.00
  • IKT -0.01
  • Stochastic Oscillator
  • XELB 69.38
  • IKT 28.21

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: